Each to their own Jimk. I prefer to look at it this way. My post consolidation purchases that’s after Dec 2017 now make up about 70% of my total holdings in SGH and growing.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025